YouMed

Search in our areas

ITA

Zambonardi

Paolo Zambonardi
Chief Executive Officer of the Italfarmaco Group

Disease: Amyotrophic Lateral Sclerosis (ALS) , Duchenne Muscular Dystrophy (DMD)

APRI INFORMAZIONI MEDICO

CHIUDI INFORMAZIONI MEDICO

all videos

Italfarmaco, between basic research and incremental innovation

Italfarmaco, between basic research and incremental innovation

Paolo Zambonardi

Italfarmaco's commitment against Duchenne's Dystrophy

Italfarmaco's commitment against Duchenne's Dystrophy

Paolo Zambonardi

The food supplements phenomenon. The specificity of the Italfarmaco approach

The food supplements phenomenon. The specificity of the Italfarmaco approach

Paolo Zambonardi

Cookies helps us to provide our services. Using these services , you agree to use of cookies on our part. OK